Last edition
News about
Coronavirus: World pharma supplier India restricts export of some ingredients, drugs
The coronavirus outbreak has disrupted businesses dependent on Chinese supplies and industry professionals say Indian generic drugmakers are likely to face supply shortages from China if the epidemic drags on. Indian pharma companies get almost 70% of the active pharmaceutical ingredients for their medicines from China.
Pharma Industry Likely To Reach $100 Billion: Gowda
D V Sadananda Gowda, Minister of Chemicals and Fertilizers, Govt of India today said that the Indian pharmaceuticals and medical devices sector has the potential to become the world leader and government will provide all necessary support.
Coronavirus impact: Is there hope for Indian pharma beyond Ides of March?
Time is ticking and Indian pharmaceutical units dependent on crucial raw materials from China - active pharmaceutical ingredients and key starting materials to make medicines in India - are waiting and watching developments unfold this month.
Dr Reddy's inks Rs 1,850-crore deal with Wockhardt; to acquire 62 brands & Baddi unit
Dr Reddy's Laboratories on Wednesday announced it would acquire Wockhardt's select divisions of branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives for consideration for Rs 1,850 crore.
Biocon receives 3 USFDA observations for insulin facility in Malaysia
At the conclusion of the inspection, the agency issued a Form 483 with three observations which we believe are procedural in nature
Abbott launches new four-strain flu vaccine for wide protection against influenza
Globally approved, this 3rd generation quadrivalent vaccine, offers wide coverage protection against four flu virus strains for children and adults vs. three strains in previous generation Sub-unit vaccines offer similar immunization benefits with better tolerability compared to other flu vaccine types, with lesser side effects.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy